Melanoma News and Research RSS Feed - Melanoma News and Research

Melanoma is a form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or in the intestines.
ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

While momentum around immunotherapies for cancer continues to build, the high cost of these therapies places them at the center of debate about how best to define and measure value in cancer care. [More]
Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of research, understanding why cancer cells become invasive has remained shrouded in mystery. [More]
Sunbed use increases number of melanoma patients and decreases age at diagnosis

Sunbed use increases number of melanoma patients and decreases age at diagnosis

Melanoma is the most dangerous type of skin cancer with the strongest increase in incidence in the last decade, and the incidence rates have never been as high as in 2014. [More]
Risk of skin cancer does not dissuade indoor tanning habits of college students, study shows

Risk of skin cancer does not dissuade indoor tanning habits of college students, study shows

White female college students in Indiana who tan indoors know they are placing themselves at risk of skin cancer and premature skin aging, but most continue to tan indoors anyway, according to a study conducted by researchers at the Richard M. Fairbanks School of Public Health at Indiana University-Purdue University Indianapolis. [More]
NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

The National Comprehensive Cancer Network has published the NCCN Guidelines for Patients and NCCN Quick Guide sheets for Brain Cancer - Gliomas—the first in a series of patient education resources focused on Brain Cancer. [More]
Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells. [More]
New report reveals 25% drop in overall cancer death rate in the U.S.

New report reveals 25% drop in overall cancer death rate in the U.S.

A steady decline over more than two decades has resulted in a 25% drop in the overall cancer death rate in the United States. The drop equates to 2.1 million fewer cancer deaths between 1991 and 2014. [More]
Future Oncology: Special issue focuses on field of psycho-oncology in cancer care

Future Oncology: Special issue focuses on field of psycho-oncology in cancer care

The Future Science Group published journal, Future Oncology, has released a special issue that examines the field of psycho-oncology, which aims to bring together the biomedical and psychosocial aspects of cancer care. [More]
Penn State researchers create smart, targeted system to attack specific cancers types

Penn State researchers create smart, targeted system to attack specific cancers types

Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. [More]
Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer. [More]
New research letter compares melanoma death and incidence by states and geographic regions

New research letter compares melanoma death and incidence by states and geographic regions

A new research letter published online by JAMA Dermatology compares melanoma death and incidence by states and in four geographic regions. [More]
Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors. [More]
UNC scientists develop new tool to study G-protein signaling

UNC scientists develop new tool to study G-protein signaling

Scientists from the UNC School of Medicine have developed a new tool for studying a key process in cells called G-protein signaling, which plays a central role in the normal functioning of cells and can go awry to cause severe disease, including cancers. [More]
Dual treatment strategies lengthen lives of mice with skin cancer

Dual treatment strategies lengthen lives of mice with skin cancer

By combining two treatment strategies, both aimed at boosting the immune system's killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. [More]
Research sheds new light on key drivers of cancer metastasis

Research sheds new light on key drivers of cancer metastasis

Latest research from New Zealand's University of Otago is shedding new light on why and how cancer cells spread from primary tumours to other parts of the body. This phenomenon - known as metastasis - causes about 90 per cent of all cancer deaths. [More]
Breast cancer patient finds new hope with potentially revolutionary treatment

Breast cancer patient finds new hope with potentially revolutionary treatment

City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein. [More]
Research findings reveal new powerful role of sunlight on immunity

Research findings reveal new powerful role of sunlight on immunity

Sunlight allows us to make vitamin D, credited with healthier living, but a surprise research finding could reveal another powerful benefit of getting some sun. [More]
HCI receives $8.8 million NIH grant to lead colon cancer study

HCI receives $8.8 million NIH grant to lead colon cancer study

Huntsman Cancer Institute at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes. [More]
How to stay safe in the sun

How to stay safe in the sun

When choosing a sunscreen, you must first consider what you will be doing when wearing it, for example if you're running, the sunscreen you choose must be able to withstand sweating. [More]
Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore. [More]
Advertisement
Advertisement